We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CTKB market cap is 779.71M. The company's latest EPS is USD -0.0929 and P/E is -64.16.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 37.09M | 49.69M | 48M | 58.23M | 44.86M |
| Operating Income | -12.16M | -9.13M | -6.42M | -1.64M | -10.73M |
| Net Income | -6.81M | -4.39M | -6.46M | 5.5M | -6.17M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 92.84M | 127.95M | 164.04M | 193.02M |
| Operating Income | 13.66M | 9.16M | -1.8M | -27.85M |
| Net Income | 3.22M | 0 | 2.58M | -12.15M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 524.58M | 525.05M | 519.43M | 494.46M | 492.07M |
| Total Liabilities | 101.12M | 100.88M | 103.91M | 101.39M | 99.45M |
| Total Equity | 423.46M | 424.18M | 415.52M | 393.06M | 392.61M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 219.98M | 463.31M | 519.48M | 494.46M |
| Total Liabilities | 41.69M | 57.92M | 93.93M | 101.39M |
| Total Equity | -16.03M | 405.39M | 425.55M | 393.06M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | 2.86M | 8k | -4.23M | 5.28M | 3.96M |
| Investing | -168.87M | -166.08M | -122.96M | -93.89M | -5.75M |
| Financing | N/A | 216k | -8.06M | -41.81M | 1.61M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 15.16M | 4.63M | -12.23M | 5.28M |
| Investing | -1.55M | -20.99M | -55.91M | -93.89M |
| Financing | 122.61M | 213.56M | 5.51M | -41.81M |
| Market Cap | 779.71M |
| Price to Earnings Ratio | -64.16 |
| Price to Sales Ratio | 4.04 |
| Price to Cash Ratio | 4.66 |
| Price to Book Ratio | 1.98 |
| Dividend Yield | - |
| Shares Outstanding | 130.82M |
| Average Volume (1 week) | 513.19k |
| Average Volume (1 Month) | 663.37k |
| 52 Week Change | -23.59% |
| 52 Week High | 9.87 |
| 52 Week Low | 3.80 |
| Spread (Intraday) | 1.08 (16.9%) |
| Company Name | Cytek Biosciences Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.cytekbio.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
